A Clinical Trial for Lennox-Gastaut Syndrome in Kids


This study is for children 2 to 17 years old with a clinical diagnosis of Lennox-Gastaut syndrome to take part in a 25-week clinical research study. The primary purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational medication(Soticlestat as add on therapy) for Lennox-Gastaut syndrome.
Individuals will be evaluated to determine their eligibility to participate in this study. Each patient who qualifies will receive either the investigational medication or a placebo, as well as study-related medical exams and study-related laboratory tests, at no cost. Compensation for time and travel may also, be available.


Currently recruiting participants: Yes

Eligible gender: Male, Female

Eligible ages: 2 to 17

Inclusion criteria:

You or your child may be eligible to participate in this trial if you or your child:
- age between 2 and 17 years
- have been diagnosed with Lennox-Gastaut Syndrome
Doctors will also evaluate other criteria to make sure you and your child qualify for the study.

Exclusion criteria:

You or your child may not be eligible to participate in this trial if you or your child:
- Received the drug Soticlestat previously
- History of HIV, hepatitis B and C
- Is currently pregnant, or breast feeding


Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

Please contact Dr. Julia Jacobs-LeVan at 4039552480 or Julia.Jacobs-LeVan@albertahealthservices.ca or study coordinator Paola Meza Santoscoy at Paola.MezaSantoscoy@albertahealthservices.ca or 403-955-5722 

Principal investigator:

Julia Jacobs-Levan

Clinical trial: